Effects of kikyo-to on sore throat pain associated with acute upper respiratory tract infection: a randomized, controlled trial
Not Applicable
- Conditions
- upper respiratory tract infection
- Registration Number
- JPRN-UMIN000030239
- Lead Sponsor
- Akashi Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with allergy to kikyo-to and lactose, patients with aldosteronism, patients with myopathy, patients with known hypokalemia, pregnant patients or patients with possibility of pregnancy, breastfeeding patients, patients who take kikyo-to, patients inurgent condition, patients who were unable to participate the study because of dementia, visual impairment and unable to answer, or complete the study form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is the difference on sore throat VAS scale between 10 minutes after kikyo-to is taken.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are the proportion of patients with sore throat score more than moderate level between 10 minutes after kikyo-to is taken.